Related Experiment Video

Updated: Jul 1, 2026

Quantifying Agonist Activity at G Protein-coupled Receptors
11:45

Quantifying Agonist Activity at G Protein-coupled Receptors

Published on: December 26, 2011

Quantitative structure-activity relationships for PPAR-gamma binding and gene transactivation of tyrosine-based

Costas Giaginis1, Stamatios Theocharis, Anna Tsantili-Kakoulidou

  • 1Department of Pharmaceutical Chemistry, School of Pharmacy, University of Athens, Panepistimiopolis, Zografou, Athens 15771, Greece.

Chemical Biology & Drug Design
|September 17, 2008
PubMed

Insights

Quantitative Structure-Activity Relationship (QSAR) models guide the design of novel tyrosine-based agonists targeting peroxisome proliferator-activated receptor-gamma (PPARγ) for diabetes and cancer therapies. Key molecular properties influencing binding affinity and gene transactivation were identified.

Area of Science:

  • Medicinal Chemistry
  • Computational Chemistry
  • Pharmacology

Background:

  • Peroxisome proliferator-activated receptor-gamma (PPARγ) is a key target for type II diabetes treatments and is being investigated for anti-cancer drug discovery.
  • Tyrosine derivatives are a significant class of PPARγ agonists, prompting interest in developing Quantitative Structure-Activity Relationship (QSAR) models for drug design.
  • QSAR models are crucial for predicting the activity of new compounds and guiding the molecular design of PPARγ agonists.

Purpose of the Study:

  • To establish robust QSAR models for a large set of tyrosine-based PPARγ agonists.
  • To identify key molecular descriptors influencing binding affinity (pKi) and gene transactivation (pEC50).
  • To explore the relationship between binding affinity and gene transactivation for improved drug design.

Main Methods:

  • Multivariate data analysis, specifically Partial Least Squares (PLS) regression, was employed.
  • A comprehensive set of molecular descriptors, including physicochemical properties and structural characteristics, was generated.
  • PLS models were developed for both binding affinity and gene transactivation data.

Main Results:

  • Two PLS models for binding affinity demonstrated satisfactory statistical performance.
  • Molecular weight, rotatable bonds, and lipophilicity positively influenced binding affinity.
  • Excess positive or negative charges and gene transactivation data complexity required separate modeling for highly active compounds, with a PLS model improving the pEC50-pKi inter-relationship.

Conclusions:

  • The study successfully developed QSAR models for tyrosine-based PPARγ agonists, identifying critical structural features for drug design.
  • Molecular weight, lipophilicity, and rotatable bonds are favorable for PPARγ binding.
  • Understanding the interplay between binding and transactivation is key for optimizing PPARγ-targeting therapeutics.

Related Concept Videos

Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
Transducer Mechanism: Nuclear Receptors01:31

Transducer Mechanism: Nuclear Receptors

Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
The Two-State Receptor Model01:29

The Two-State Receptor Model

The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with one...
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...
Quantitative Aspects of Drug-Receptor Interaction01:30

Quantitative Aspects of Drug-Receptor Interaction

The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower Kd...
G Protein-coupled Receptors01:15

G Protein-coupled Receptors

G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...